Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2007 by Korea Otsuka Pharmaceutical Co., Ltd..
Recruitment status was:  Recruiting
Otsuka Pharmaceutical Co., Ltd.
Information provided by:
Korea Otsuka Pharmaceutical Co., Ltd. Identifier:
First received: October 25, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Condition Intervention
Oral Mucositis
Other: no intervention study

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Further study details as provided by Korea Otsuka Pharmaceutical Co., Ltd.:

Primary Outcome Measures:
  • incidence and severity of oral mucositis

Study Start Date: October 2007
Estimated Study Completion Date: March 2008

Ages Eligible for Study:   19 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion Criteria:

  • Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
  • Patients with performance status of ECOG score is more than 3
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00549952

Contact: Yonghui Jeong 82-2-3465-3956
Contact: Boyoun Seo 82-2-3465-5485 byseo@otsuka.cokr

Korea, Republic of
Seoul National University hospital Recruiting
Seoul, Korea, Republic of, 110-744
Principal Investigator: Do-Youn Oh         
Sponsors and Collaborators
Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Principal Investigator: Do-Youn Oh, PhD Seoul National University Hospital
  More Information Identifier: NCT00549952     History of Changes
Other Study ID Numbers: 256-KOB-0701
Study First Received: October 25, 2007
Last Updated: October 25, 2007

Additional relevant MeSH terms:
Gastrointestinal Diseases
Digestive System Diseases
Mouth Diseases
Stomatognathic Diseases processed this record on May 23, 2017